Cambridge Prisms: Antimicrobial Resistance serves as an essential platform for the dissemination of high-quality translational research, innovation, and informed discourse on antimicrobial resistance. Beyond the traditional boundaries of scientific inquiry, the journal aims to foster interdisciplinary collaboration by providing a forum where researchers, clinicians, veterinarians, policymakers, regulators, and industry and business stakeholders converge to share insights and solutions. The journal advocates for increased global efforts to address antimicrobial resistance and protect the efficacy of current and new antimicrobial medicines.
We accept the following types of articles:
Overview Review*
Review* (standard review)
Research article*
Perspective Comment** (invited only)
Case studies*
Rapid Communication*
* For the purposes of Gold Open Access funding, this journal considers these article types to be research articles. All or part of the publication costs for these article types may be covered by one of the agreements Cambridge University Press has made to support open access. For authors not covered by an agreement, and without APC funding, please see this journal's open access options for instructions on how to request an APC waiver.
** No APCs are required for these article types.